Their results showed teratoma/outgrowth rates of non-sorted (NS) 27% (4/15), FT 18% (3/17) and 0% (0/11) in GP2-enriched pancreatic progenitors, demonstrating that targeted purification has the potential to eliminate teratoma formation [70]. Here, GP2 is linked to teratoma.